Page 1 of 1

Fingolimod granted FDA Breakthrough Therapy designation...

Posted: Tue Dec 19, 2017 6:47 am
by MSUK
Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS

Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms

Image